Company Filing History:
Years Active: 2018
Title: Innovations in Ablation Technology by James Holte
Introduction
James Holte is an accomplished inventor based in Minneapolis, MN (US). He has made significant contributions to the field of medical technology, particularly in the area of ablation procedures. His innovative work focuses on enhancing the safety and effectiveness of these procedures through advanced methods and systems.
Latest Patents
James Holte holds a patent for an invention titled "Electrogram-based ablation control." This patent describes methods, devices, and systems for predicting, diagnosing, and preventing adverse events during an ablation procedure. The invention outlines a method for providing ablation energy, which includes receiving a first signal based on the biological activity of a patient's tissue. The method further involves analyzing the first signal to yield a first data set, establishing a threshold parameter according to the first data set, and providing ablation energy for the ablation of a biological site. Holte's patent is a testament to his innovative approach to improving patient outcomes during medical procedures. He has 1 patent to his name.
Career Highlights
James Holte is currently employed at St. Jude Medical, Atrial Fibrillation Division, Inc. His role at the company allows him to work on cutting-edge technologies that aim to improve the quality of care for patients with atrial fibrillation. His expertise in the field has positioned him as a valuable asset to the organization.
Collaborations
Throughout his career, James has collaborated with talented professionals, including Saurav Paul and Charles Bryan Byrd. These collaborations have contributed to the advancement of technologies in the medical field, particularly in the realm of ablation procedures.
Conclusion
James Holte's innovative contributions to ablation technology highlight his commitment to improving patient care through advanced medical solutions. His work continues to influence the field and pave the way for future innovations.